Trent Basarsky - 908 Devices VP Devel
| MASS Stock | USD 4.53 0.37 8.89% |
Insider
Trent Basarsky is VP Devel of 908 Devices
| Age | 56 |
| Address | 645 Summer Street, Boston, MA, United States, 02210 |
| Phone | 857 254 1500 |
| Web | https://908devices.com |
908 Devices Management Efficiency
The company has return on total asset (ROA) of (0.1675) % which means that it has lost $0.1675 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5156) %, meaning that it created substantial loss on money invested by shareholders. 908 Devices' management efficiency ratios could be used to measure how well 908 Devices manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.6 in 2025. Return On Capital Employed is likely to gain to -0.54 in 2025. At this time, 908 Devices' Total Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 207.8 M in 2025, whereas Other Assets are likely to drop slightly above 962.9 K in 2025.Similar Executives
| Showing other executives | INSIDER Age | ||
| John Martin | Butterfly Network | 62 | |
| Jennifer Kirk | Medtronic PLC | 50 | |
| Alan Douville | Stryker | N/A | |
| Sridhar Kosaraju | Nevro Corp | 42 | |
| Vance Brown | Boston Scientific Corp | 55 | |
| Jereme Sylvain | DexCom Inc | 44 | |
| Christopher Scoggins | Abbott Laboratories | 54 | |
| Elazer Edelman | Butterfly Network | 64 | |
| Louis Morrone | Abbott Laboratories | 44 | |
| Leana Wen | Glaukos Corp | 37 | |
| Mory Gharib | Glaukos Corp | N/A | |
| Tomas Navratil | Glaukos Corp | ||
| S Phanstiel | Butterfly Network | 62 | |
| David Haffner | Glaukos Corp | N/A | |
| Tamara Dillon | Butterfly Network | N/A | |
| Gregory Ahlberg | Abbott Laboratories | 54 | |
| John Hammergren | Butterfly Network | 62 | |
| Spencer Stiles | Stryker | 48 | |
| Michael Pederson | Abbott Laboratories | 59 | |
| Andrea Wainer | Abbott Laboratories | 55 | |
| Diana Scherer | Glaukos Corp | N/A | |
Management Performance
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.17 |
908 Devices Leadership Team
Elected by the shareholders, the 908 Devices' board of directors comprises two types of representatives: 908 Devices inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 908. The board's role is to monitor 908 Devices' management team and ensure that shareholders' interests are well served. 908 Devices' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 908 Devices' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Knopp, CEO, CoFounder | ||
| Joseph IV, CFO Treasurer | ||
| Steve Araiza, CoFounder | ||
| Scott Miller, Cofounder Engineering | ||
| JD Esq, Chief Secretary | ||
| Christopher Brown, CoFounder Officer | ||
| Andrew Bartfay, CoFounder Development | ||
| Trent Basarsky, VP Devel | ||
| Michael Jobin, CoFounder Development | ||
| Maura Fitzpatrick, VP Marketing | ||
| Don Osmer, Vice Resources | ||
| Barbara Russo, VP Communications |
908 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is 908 Devices a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (1.21) % | ||||
| Operating Margin | (0.56) % | ||||
| Current Valuation | 85.57 M | ||||
| Shares Outstanding | 35.33 M | ||||
| Shares Owned By Insiders | 8.00 % | ||||
| Shares Owned By Institutions | 63.48 % | ||||
| Number Of Shares Shorted | 2.28 M | ||||
| Price To Book | 1.30 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 908 Stock Analysis
When running 908 Devices' price analysis, check to measure 908 Devices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 908 Devices is operating at the current time. Most of 908 Devices' value examination focuses on studying past and present price action to predict the probability of 908 Devices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 908 Devices' price. Additionally, you may evaluate how the addition of 908 Devices to your portfolios can decrease your overall portfolio volatility.